Congenital disorders of the skin, recessive dystrophic epidermolysis bullosa research hub

Mesenchymal stromal cell therapy for children with recessive dystrophic epidermolysis bullosa

This UK clinical trial is testing a stem cell drip called CORDStrom for children aged 6 months to 16 years with recessive dystrophic epidermolysis bullosa (RDEB). RDEB causes fragile, easily blistered skin. Researchers want to see if these special cells can safely ease pain, reduce itching, and help wounds heal.